Laurent Fischer, CEO, President and Director at Adverum Biotechnologies, Inc. (ADVM), bought 25,000 shares at $1.11 ($28K) on 2022-04-20, disclosed to the SEC on 2022-04-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ADVM | SELL | 2023-03-17 | $32K | — | Filing → |
| ADVM | SELL | 2022-09-21 | $44K | — | Filing → |
| ADVM | BUY | 2021-12-10 | $46K | — | Filing → |